Semi-Annual Consolidated Statement Of Comprehensive Income

TAIKO PHARMACEUTICAL CO., LTD. - Filing #7344643

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Semi-annual consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-3,724,000,000 JPY
-3,724,000,000 JPY
-3,611,000,000 JPY
-3,724,000,000 JPY
-3,724,000,000 JPY
-4,954,000,000 JPY
-4,954,000,000 JPY
-4,895,000,000 JPY
-4,954,000,000 JPY
-4,954,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
91,000,000 JPY
JPY
Foreign currency translation adjustment
53,000,000 JPY
98,000,000 JPY
Other comprehensive income
145,000,000 JPY
98,000,000 JPY
Comprehensive income
-3,466,000,000 JPY
-4,796,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-3,466,000,000 JPY
-4,796,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.